Risk Capital Partners, the private equity firm chaired by Luke Johnson, today announces that it has bought a majority stake in Xstrahl, a medical devices business that designs and delivers [...]
Xstrahl sponsors and attends a wide range of Radiation oncology industry conferences, seminars and events. You will find us at ESTRO, UKRO, ASTRO and many other events throughout the year.
For over 20 years Xstrahl has been shaping the development of superficial and orthovoltage therapies. Responding to very real clinical need and drawing on the knowledge and expertise of healthcare professionals, we are committed to providing innovative radiotherapy solutions that deliver positive patient outcomes.
Xstrahl’s pioneering X-ray research solutions include custom cabinet irradiators that are used for delivering precise radiation doses to in vivo and in vitro biological specimens, the industry–leading SARRP radiation research platform which enables Image Guided Micro Irradiation (IGMI™) techniques with high resolution imaging.